StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International cash

Cash and short-term investments held at the end of each period.

Charles River Laboratories International's cash was $192.03M at Jun 27, 2026. For fiscal 2025 it was $213.77M, up 4.0% from the year before. Over ten years it grew 4.3% a year on average. The highest annual figure on record is $284.48M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 27, 2025$213.77M+4.0%
FY2024Dec 28, 2024$205.57M-27.7%
FY2023Dec 30, 2023$284.48M+17.9%
FY2022Dec 31, 2022$241.21M-2.5%
FY2021Dec 25, 2021$247.38M+5.7%
FY2020Dec 26, 2020$234.14M-2.8%
FY2019Dec 28, 2019$240.99M+21.6%
FY2018Dec 29, 2018$198.20M+1.7%
FY2017Dec 30, 2017$194.82M+57.5%
FY2016Dec 31, 2016$123.67M-12.0%
FY2015Dec 26, 2015$140.48M-13.6%
FY2014Dec 27, 2014$162.58M-2.7%
FY2013Dec 28, 2013$167.09M+43.5%
FY2012Dec 29, 2012$116.47M+56.8%
FY2011Dec 31, 2011$74.26M-60.7%
FY2010Dec 25, 2010$188.99M+3.5%
FY2009Dec 26, 2009$182.57M-25.0%
FY2008Dec 27, 2008$243.59M+8.0%
FY2007Dec 29, 2007$225.45M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 27, 2026$192.03M+5.0%
Q1 FY2026Mar 28, 2026$191.83M-16.4%
Q4 FY2025Dec 27, 2025$213.77M+4.0%
Q3 FY2025Sep 27, 2025$207.10M-1.5%
Q2 FY2025Jun 28, 2025$182.82M+2.0%
Q1 FY2025Mar 29, 2025$229.36M-29.9%
Q4 FY2024Dec 28, 2024$205.57M-27.7%
Q3 FY2024Sep 28, 2024$210.17M+33.7%
Q2 FY2024Jun 29, 2024$179.21M-14.2%
Q1 FY2024Mar 30, 2024$327.04M+56.6%
Q4 FY2023Dec 30, 2023$284.48M+17.9%
Q3 FY2023Sep 30, 2023$157.17M-20.3%
Q2 FY2023Jul 1, 2023$208.78M+0.3%
Q1 FY2023Apr 1, 2023$208.89M-14.0%
Q4 FY2022Dec 31, 2022$241.21M-2.5%
Q3 FY2022Sep 24, 2022$197.13M-7.7%
Q2 FY2022Jun 25, 2022$208.22M-7.0%
Q1 FY2022Mar 26, 2022$242.93M-47.9%
Q4 FY2021Dec 25, 2021$247.38M+5.7%
Q3 FY2021Sep 25, 2021$213.57M-12.4%
Q2 FY2021Jun 26, 2021$224.01M-44.4%
Q1 FY2021Mar 27, 2021$466.44M+24.9%
Q4 FY2020Dec 26, 2020$234.14M-2.8%
Q3 FY2020Sep 26, 2020$243.84M+47.2%
Q2 FY2020Jun 27, 2020$402.95M+100.0%
Q1 FY2020Mar 28, 2020$373.37M+193.5%
Q4 FY2019Dec 28, 2019$240.99M+21.6%
Q3 FY2019Sep 28, 2019$165.61M+14.9%
Q2 FY2019Jun 29, 2019$201.48M+4.3%
Q1 FY2019Mar 30, 2019$127.22M-33.2%
Q4 FY2018Dec 29, 2018$198.20M+1.7%
Q3 FY2018Sep 29, 2018$144.10M-6.4%
Q2 FY2018Jun 30, 2018$193.20M+38.1%
Q1 FY2018Mar 31, 2018$190.32M+40.6%
Q4 FY2017Dec 30, 2017$194.82M+57.5%
Q3 FY2017Sep 30, 2017$153.97M+45.6%
Q2 FY2017Jul 1, 2017$139.94M–
Q1 FY2017Apr 1, 2017$135.40M–
Q4 FY2016Dec 31, 2016$123.67M–
Q3 FY2016Sep 24, 2016$105.72M–

More Charles River Laboratories International figures

See a number that looks wrong?